Origimm Biotechnology

ProVaDis: Protection-based Vaccine Discovery

ORIGIMM STARTS COLLABORATION WITH DR. ANDREJ TRAMPUZ AT CHARITE, BERLIN IN THE FIELD OF IMPLANT-ASSOCIATED INFECTIONS, JULY 2015

Following the discovery of the significant role that P. acnes plays also in implant-associated infections, we initiated a collaboration with Dr. Trampuz and his Pro-Implant Foundation to research the applicability of Origimm’s P. acnes vaccine candidate to prevent the implant infections associated with this pathogen.